NYSE: CYBN - Cybin Inc.

Altı ay boyunca karlılık: -2.35%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Cybin Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Cybin Inc.

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in Phase 1/2a clinical trial to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine, which is in Phase 1 clinical trial for treating generalized anxiety disorders; and CYB005, a phenethylamine derivative, which in in preclinical stage to treat neuroinflammation.

daha fazla ayrıntı
It has also developed EMBARK, a psychological support model that integrates clinical approaches to promote supportive healing with psychedelic medicine. The company is headquartered in Toronto, Canada.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2019-09-13
ISIN CA23256X1006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.cybin.com
Цена ао 7.3
Günlük fiyat değişimi: +3.7% (7.3)
Haftalık fiyat değişimi: +3.84% (7.29)
Aylık fiyat değişimi: -19.12% (9.36)
3 ayda fiyat değişimi: -22.6% (9.78)
Altı ayda fiyat değişimi: -2.35% (7.752)
Yıllık fiyat değişimi: +1 610.73% (0.4425)
3 yılda fiyat değişimi: +870.51% (0.78)
5 yılda fiyat değişimi: +3 738.74% (0.1972)
Yılbaşından bu yana fiyat değişimi: -18.78% (9.32)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 0.6298 10
P/E 0 0
EV/EBITDA 0.3199 10
Toplam: 5

Yeterlik

İsim Anlam Seviye
ROA, % -40.45 0
ROE, % -42.43 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.0037 10
Toplam: 8.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 0 0
karlılık Ebitda, % -818600 0
karlılık EPS, % 32682.95 10
Toplam: 6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Point72 Asset Management, L.P. 30061112 4.04
Anson Funds Management LP 8924494 1.2
Alyeska Investment Group, L.P. 5683196 0.76
CVI Holdings, LLC 5225262 0.7
AdvisorShares Investments, LLC 1859181 0.25
PDS Planning, Inc 1153120 0.16
Propel Bio Management, LLC 850000 0.11
Simplify Asset Management, Inc. 500000 0.07
FNY Investment Advisers, LLC 402000 0.05
Lewis Asset Management, LLC 282000 0.04



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Eric So L.L.B. Co-Founder, President & Executive Chairman 458.88k 1976 (49 yıllar)
Mr. Douglas L. Drysdale Chief Executive Officer 613.44k 1970 (55 yıllar)
Mr. Paul Glavine Co-Founder, Chief Growth Officer & Director 458.88k 1989 (36 yıllar)
Mr. Greg Cavers Chief Financial Officer 242.09k 1971 (54 yıl)
Mr. Aaron Bartlone Chief Operating Officer 379.12k 1967 (58 yıllar)
Mr. John Kanakis Co-Founder 704.03k 1981 (44 yıl)
Dr. Alex L. Nivorozhkin Ph.D. Chief Scientific Officer N/A 1960 (65 yıllar)
Ms. Lori Challenger Chief Compliance, Ethics & Administrative Officer N/A
Mr. Gabriel Fahel Chief Legal Officer & Corporate Secretary N/A 1976 (49 yıllar)
Mr. George Tziras Chief Business Officer & Director 1981 (44 yıl)

Adres: Canada, Toronto, 100 King Street West - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.cybin.com